{"id":53524,"date":"2023-02-01T15:02:48","date_gmt":"2023-02-01T14:02:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\/"},"modified":"2023-02-01T15:02:48","modified_gmt":"2023-02-01T14:02:48","slug":"osi-systems-receives-3-million-order-for-patient-monitoring-systems","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\/","title":{"rendered":"OSI Systems Receives $3 Million Order for Patient Monitoring Systems"},"content":{"rendered":"
\n

HAWTHORNE, Calif.–(BUSINESS WIRE)–OSI Systems, Inc. (the \u201cCompany\u201d or \u201cOSI Systems\u201d) (NASDAQ: OSIS) today announced that its Healthcare division, Spacelabs Healthcare\u00ae<\/sup>, received an order valued at approximately $3 million to provide patient monitoring solutions and support services to a Canadian based hospital. The Company expects to provide Xhibit\u00ae<\/sup> Central Stations, AriaTele\u00ae<\/sup> telemetry, Xprezzon\u00ae<\/sup>, Qube\u00ae<\/sup> and Qube Mini\u00ae<\/sup> patient monitors along with its Clinical Access\u00ae<\/sup> decision support and interface software.\n<\/p>\n

\n\u201cWe are delighted to receive this significant order and to provide this customer with the breadth of our hardware, patient management and connectivity solutions,\u201d commented Deepak Chopra, OSI Systems\u2019 Chairman and CEO.\n<\/p>\n

\nAbout OSI Systems<\/b>\n<\/p>\n

\nOSI Systems is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries. The Company combines more than 40 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end product markets. For more information on OSI Systems or any of its subsidiary companies, visit www.osi-systems.com<\/a>. News Filter: OSIS-G\n<\/p>\n

\nForward-Looking Statements<\/b>\n<\/p>\n

\nThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to OSI Systems\u2019 current expectations, beliefs, and projections concerning matters that are not historical facts. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions, and contingencies, many of which are outside OSI Systems\u2019 control and which may cause actual results to differ materially from those described in or implied by any forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are based on currently available information and speak only as of the date on which they are made. OSI Systems assumes no obligation to update any forward-looking statement made in this press release that becomes untrue because of subsequent events, new information, or otherwise, except to the extent it is required to do so in connection with its ongoing requirements under Federal securities laws. For a further discussion of factors that could cause OSI Systems\u2019 future results to differ materially from any forward-looking statements, see the section entitled “Risk Factors” in OSI Systems\u2019 most recently filed Annual Report on Form 10-K and other risks described therein and in documents subsequently filed by OSI Systems from time to time with the Securities and Exchange Commission.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nOSI Systems, Inc.
\n
Ajay Vashishat
\n
Vice President, Business Development
\n
310-349-2237
\n
avashishat@osi-systems.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

HAWTHORNE, Calif.–(BUSINESS WIRE)–OSI Systems, Inc. (the \u201cCompany\u201d or \u201cOSI Systems\u201d) (NASDAQ: OSIS) today announced that its Healthcare division, Spacelabs Healthcare\u00ae, received an order valued at approximately $3 million to provide patient monitoring solutions and support services to a Canadian based hospital. The Company expects to provide Xhibit\u00ae Central Stations, AriaTele\u00ae telemetry, Xprezzon\u00ae, Qube\u00ae and Qube … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53524","6":"format-standard","7":"category-industry"},"yoast_head":"\nOSI Systems Receives $3 Million Order for Patient Monitoring Systems - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OSI Systems Receives $3 Million Order for Patient Monitoring Systems - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"HAWTHORNE, Calif.–(BUSINESS WIRE)–OSI Systems, Inc. (the \u201cCompany\u201d or \u201cOSI Systems\u201d) (NASDAQ: OSIS) today announced that its Healthcare division, Spacelabs Healthcare\u00ae, received an order valued at approximately $3 million to provide patient monitoring solutions and support services to a Canadian based hospital. The Company expects to provide Xhibit\u00ae Central Stations, AriaTele\u00ae telemetry, Xprezzon\u00ae, Qube\u00ae and Qube ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-01T14:02:48+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"OSI Systems Receives $3 Million Order for Patient Monitoring Systems\",\"datePublished\":\"2023-02-01T14:02:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\\\/\"},\"wordCount\":442,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\\\/\",\"name\":\"OSI Systems Receives $3 Million Order for Patient Monitoring Systems - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2023-02-01T14:02:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OSI Systems Receives $3 Million Order for Patient Monitoring Systems\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OSI Systems Receives $3 Million Order for Patient Monitoring Systems - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\/","og_locale":"en_US","og_type":"article","og_title":"OSI Systems Receives $3 Million Order for Patient Monitoring Systems - Pharma Trend","og_description":"HAWTHORNE, Calif.–(BUSINESS WIRE)–OSI Systems, Inc. (the \u201cCompany\u201d or \u201cOSI Systems\u201d) (NASDAQ: OSIS) today announced that its Healthcare division, Spacelabs Healthcare\u00ae, received an order valued at approximately $3 million to provide patient monitoring solutions and support services to a Canadian based hospital. The Company expects to provide Xhibit\u00ae Central Stations, AriaTele\u00ae telemetry, Xprezzon\u00ae, Qube\u00ae and Qube ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-01T14:02:48+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"OSI Systems Receives $3 Million Order for Patient Monitoring Systems","datePublished":"2023-02-01T14:02:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\/"},"wordCount":442,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\/","url":"https:\/\/pharma-trend.com\/en\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\/","name":"OSI Systems Receives $3 Million Order for Patient Monitoring Systems - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2023-02-01T14:02:48+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/osi-systems-receives-3-million-order-for-patient-monitoring-systems\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"OSI Systems Receives $3 Million Order for Patient Monitoring Systems"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53524","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53524"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53524\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53524"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53524"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53524"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}